Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$200M |
| 2 |
Hormel Foods
HRL
|
+$128M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$125M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$125M |
| 5 |
RB Global
RBA
|
+$96.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$130M |
| 2 |
Q2 Holdings
QTWO
|
+$120M |
| 3 |
P
Everpure Inc
P
|
+$109M |
| 4 |
THS
Treehouse Foods
THS
|
+$73M |
| 5 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.06% |
| 2 | Technology | 19.41% |
| 3 | Consumer Staples | 14.41% |
| 4 | Industrials | 13.49% |
| 5 | Financials | 13.38% |
Similar funds
Champlain Investment Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Champlain Investment Partners held 141 positions worth $19.2B, up 10% from $17.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Champlain Investment Partners deployed $1.19B of net new capital in Q1 2021, opening 19 new positions and adding to 87 existing holdings. Its largest new stake was Clorox: 1,039,265 shares worth $200M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Ulta Beauty, an estimated $130M trimmed.
- Champlain Investment Partners's largest Q1 2021 buy was Clorox: 1,039,265 shares worth $200M.
- Champlain Investment Partners added most to RB Global in Q1 2021, an estimated $96.2M increase.
- Champlain Investment Partners's biggest Q1 2021 reduction was Ulta Beauty, cutting an estimated $130M.
- Champlain Investment Partners fully exited Pluralsight, Inc. Class A Common Stock in Q1 2021, selling an estimated $71M.
- Champlain Investment Partners's ten largest holdings make up 18% of its $19.2B portfolio in Q1 2021.
- Champlain Investment Partners opened 19 new positions and closed 5 in Q1 2021.
- Champlain Investment Partners's portfolio value rose 10% quarter-over-quarter to $19.2B.
Based on Champlain Investment Partners's 13F filing for Q1 2021, filed 13 May 2021.